The effects of aggression on symptom severity and treatment response in a trial of cognitive behavioral therapy for panic disorder
The effects of aggression on symptom severity and treatment response in a trial of cognitive behavioral therapy for panic disorder
复制标题
DOI：
10.1016/j.comppsych.2015.04.012
复制
发表时间：
2015-07-01
影响因子：
7.3
通讯作者：
Barlow, David H.
中科院分区：
文献类型：
--
作者：
Cassiello-Robbins, Clair;Conklin, Laren R.;Barlow, David H.
背景资料：先前的研究表明，恐慌症患者比其他焦虑症患者表现出更高水平的攻击性。这种攻击性与更严重的心理学和人际关系问题有关。然而，很少有研究探讨是否更高水平的攻击性与更差的治疗反应在此population.Methods：本研究试图检查协会的攻击性与惊恐障碍症状的严重程度在一个样本的379名患者参加了一项试验，检查长期战略治疗惊恐障碍。我们发现攻击性与较高的惊恐障碍症状、焦虑、抑郁和功能障碍的基线水平显著相关。此外，我们发现，患者较高的侵略没有达到相同的水平，改善一般性焦虑症状的治疗过程中相比，患者较低的侵略，甚至当控制基线焦虑症状severity.Conclusion：这些结果表明，需要更多的研究与焦虑症患者较高的侵略，因为他们可能是一组需要额外的治疗考虑。(C)2015 Elsevier Inc. All rights reserved.
Background: Previous research suggests that patients with panic disorder exhibit higher levels of aggression than patients with other anxiety disorders. This aggression is associated with more severe symptomatology and interpersonal problems. However, few studies have examined whether higher levels of aggression are associated with a worse treatment response in this population.Methods: The present study sought to examine the association of aggression with panic disorder symptom severity in a sample of 379 patients who participated in a trial examining long-term strategies for the treatment of panic disorder.Results: We found that aggression was significantly associated with higher baseline levels of panic disorder symptoms, anxiety, depression, and functional impairment. Further, we found that patients higher in aggression did not achieve the same level of improvement in general anxiety symptoms during treatment compared to patients lower in aggression, even when controlling for baseline anxiety symptom severity.Conclusion: These results suggest that more research is needed concerning patients with anxiety disorders with higher aggression, as they may be a group in need of additional treatment considerations. (C) 2015 Elsevier Inc. All rights reserved.